Podcasts about World Diabetes Day

 It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: cancer reserach may lead to T1D treatment, GLP-1 oral pill moves forward, Tandem pharmacy moves, Medtronic-Abbott sensor unveield, parents of kids with T1D see income drop, Mannkind submits Afrezza for pediatrics, diabetes scholarships and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Cornell researchers have developed an implant system that can treat type 1 diabetes by supplying extra oxygen to densely packed insulin-secreting cells, without the need for immunosuppression. The system could also potentially provide long-term treatment for a range of chronic diseases. This lab has produced previous implantable devices that have proved effective in controlling blood sugar in diabetic mice, but they can only last so long. "It's the proof of concept. We really proved that oxygenation is important, and oxygenation will support high cell-density capsules," Tempelman said. "The capsules are immune protective and last for a long time without having some kind of fouling of the membrane. The body never likes it when you put a foreign substance in. So that's the engineering in the Ma Lab, to look for materials and coatings for the materials that are immune protective, but also don't invoke excess response from the body because of the material." The next step will be to implant the system in a pig model, and also test it with human stem cells. The researchers are interested in eventually trying to use the system for implanting different cell types in humans for long-term treatment of chronic diseases, according to Tempelman, who is CEO of Persista Bio Inc., a new startup she founded with Ma and Flanders that is licensing these technologies. https://medicalxpress.com/news/2025-08-implant-diabetes-oxygenating-insulin-cells.html XX Mayo Clinic cancer research may be big news for T1D. After identifying a sugar molecule that cancer cells use on their surfaces to hide from the immune system, the researchers have found the same molecule may eventually help in the treatment of type 1. Cancer cells use a variety of methods to evade immune response, including coating themselves in a sugar molecule known as sialic acid. The researchers found in a preclinical model of type 1 diabetes that it's possible to dress up beta cells with the same sugar molecule, enabling the immune system to tolerate the cells. The findings show that it's possible to engineer beta cells that do not prompt an immune response   In the preclinical models, the team found that the engineered cells were 90% effective in preventing the development of type 1 diabetes. The beta cells that are typically destroyed by the immune system in type 1 diabetes were preserved.     https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-find-sugar-coating-cells-can-protect-those-typically-destroyed-in-type-1-diabetes/ XX A daily pill may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as the popular injectable drugs Mounjaro and Ozempic, according to results of a clinical trial announced by Eli Lilly on Thursday morning.   The drug, orforglipron, is a GLP-1, a class of drugs that have become blockbusters because of their weight-loss effects. But the GLP-1s on the market now are expensive, must be kept refrigerated and must be injected. A pill that produces similar results has the potential to become far more widely used, though it is also expected to be expensive.   Lilly said it would seek approval from the Food and Drug Administration later this year to market orforglipron for obesity and early in 2026 for diabetes. https://www.nytimes.com/2025/04/17/health/pill-glp-1-eli-lilly.html XX Use of diabetes technology has dramatically increased and glycemic control has improved among people with type 1 diabetes (T1D) in the US over the past 15 years, but at the same time, overall achievement of an A1c level < 7% remains low and socioeconomic and racial disparities have widened. These findings came from an analysis of national electronic health records of nearly 200,000 children and adults with T1D by Michael Fang, PhD, of the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues. The study was published online on August 11, 2025, in JAMA Network Open. Use of continuous glucose monitors (CGMs) increased substantially from 2009-2011 to 2021-2023, from less than 5% in both children and adults to more than 80% and over half, respectively. While A1c levels did drop over the 15 years, just 1 in 5 children and slightly over a quarter of adults achieved a level < 7%. The average A1c level stayed above 8%, with ethnic minorities and low-income patients seeing the smallest gains.       https://www.medscape.com/viewarticle/diabetes-tech-use-rise-a1c-reductions-still-lag-2025a1000lc9 XX Inflammation may predict how well people with diabetes respond to depression treatment, and the effects differ dramatically between type 1 and type 2 diabetes. Diabetes and depression often appear together. Indeed, depression is more than three times more prevalent in people with type 1 diabetes (T1D) and nearly twice as prevalent in people with type 2 diabetes (T2D). When they appear together, treatment for depression can vary widely. In a new study, researchers from the German Diabetes Center (DDZ), the Research Institute of the Diabetes Academy Mergentheim (FIDAM), and the German Center for Diabetes Research (DZD) investigated how inflammation in the body relates to improvement in depression symptoms in people with T1D and T2D. The researchers combined data from three previous German randomized clinical trials that aimed to reduce elevated depressive symptoms and diabetes distress in people with type 1 or type 2 diabetes. Diabetes distress is characterized by feelings of overwhelm, frustration, guilt and worry about diabetes management and its potential complications. A total of 332 participants with T1D and 189 with T2D who had completed both a baseline and 12-month follow-up examination were included in the present study. Measures included depression using the Center for Epidemiological Studies Depression scale (CES-D), blood tests for 76 inflammatory biomarkers, and symptoms broken down into cognitive-affective (e.g., feeling hopeless), somatic (e.g., poor sleep, fatigue), and anhedonia (loss of pleasure) clusters.   After adjusting for factors like age, body mass index (BMI), diabetes duration, cholesterol, and co-existing illnesses, the researchers found that in patients with T1D, higher baseline inflammation was linked to smaller improvements in depression. Inflammation seemed to be more connected to physical/somatic symptoms in T1D patients. In those with T2D, higher baseline inflammation was linked to greater improvements in depression. For these patients, the effect was strongest for cognitive-affective and anhedonia – so, emotional and motivational – symptoms.   The researchers weren't sure what caused the difference between T1D and T2D, but they suggest it might be due to the different forms of immune activation seen in each condition. That is, autoimmune processes in type 1 and metabolic inflammation in type 2. https://newatlas.com/health-wellbeing/inflammation-diabetes-depression-treatment/ XX Parents of children diagnosed with type 1 diabetes suffer an income drop in the years following the diagnosis. The impact is more pronounced in mothers, especially mothers of children diagnosed in preschool years. And these findings come from a European study.. not the US. Previous research has shown that parents of children with type 1 diabetes are at increased risk of stress-related symptoms and may need to reduce their working hours. "In our study, we observed reduced parental work-related incomes in the years following the child's type 1 diabetes diagnosis. The drop was larger in mothers than in fathers. Since mothers earned significantly less than fathers in absolute terms, even before the child fell ill, the relative drop in mothers was 6.6% the year following diagnosis compared to 1.5% in fathers. We further note the greatest impact on work-related incomes in mothers of children diagnosed at preschool age," says Beatrice Kennedy, physician at the Endocrine and Diabetes unit at Uppsala University Hospital and Associate Professor of Medical Epidemiology at Uppsala University, who led the study. This is a huge study, builds on data from national population and health registers and the Swedish Child Diabetes Register (Swediabkids). The study includes the parents of more than 13,000 children diagnosed with type 1 diabetes in Sweden in 1993−2014, as well as more than half a million parents in the general population who have children not diagnosed with diabetes.   The researchers observed that the maternal pension-qualifying incomes (a composite outcome including work-related income and societal benefits) initially increased after the child's diagnosis. This was attributable to mothers applying for the parental care allowance from the Swedish Social Insurance Agency. The parental care allowance was intended to compensate for disease-related loss of work-related income and contribute toward disease-specific costs.   When the research team investigated long-term effects in mothers, they found that the pension-qualifying incomes gradually decreased after eight years, and had not recovered by the end of follow-up − 17 years after the children were diagnosed. https://www.news-medical.net/news/20250811/Mothers-face-greater-financial-impact-following-childe28099s-type-1-diabetes-diagnosis.aspx XX The U.S. Department of Justice has reached a settlement with Metro Nashville Public Schools after allegations that the district violated the Americans with Disabilities Act.   The parents of a student at the Ross Early Learning Center requested that the school monitor their child's glucose monitor. Investigators found the school refused to do so, despite the child's Type 1 Diabetes diagnosis.   As part of the settlement, MNPS agreed to change its policies to allow the use of these devices, ensure trained staff can monitor them throughout the entire school day and at school activities, and improve communication with parents. https://www.wsmv.com/2025/08/12/metro-nashville-public-schools-settles-allegations-it-discriminated-against-students-with-diabetes/ XX Modular Medical has unveiled Pivot, its next-generation insulin patch pump technology aimed at simplifying diabetes care. The company announced its new pump for “almost-pumpers” at the Association of Diabetes Care & Education Specialists (“ADCES”) Conference in Phoenix, Arizona this weekend. It aims for Pivot to target adults with a user-friendly, affordable design.   Modular Medical's current pump, the MODD1, won FDA clearance nearly a year ago. It features new microfluidics technology to allow for the low-cost pumping of insulin. The system has a reservoir size of 300 units/3mL. Users can monitor the pump activity with their cell phone and do not require an external controller. The pump uses a provided, single-use, disposable battery.   The company announced recently that it validated its insulin pump cartridge line for human-use production in the U.S. Days later, it reported the first human use of the MODD1 pump.   Now, it has taken the next steps with the debut of a next-gen pump, set for FDA submission in October.   Modular Medical also gamifies diabetes care The company also said ADCES is the place where it will showcase the first playable level of its new Pivot pump gamified trainin module. Level Ex, a developer of medical games, develops the module.   Modular Medical said gamification offers a way to make medical training more effective and efficient while improving information retention. Given the complexity in pump uptake, the company hopes to provide an easy way to bring its technology to clinicians and patients.   The company expects to have training modules available at the same time as the pump's planned launch in 2026.   “Level One is free because diabetes mastery shouldn't come with a price tag,” Sam Glassenberg, CEO of Level Ex, said. “Modular Medical is breaking barriers too – bringing pump therapy to more people through smart, accessible design. Together, we intend to make diabetes management simpler and more inclusive.   “People learn best through play – and we believe they want to learn about insulin pumps the same way. In Level One, players aren't just mastering diabetes management through gameplay – they're asking to ‘play' with pumps: to explore how they work, understand their benefits, and build confidence before using them in real life. Our partnership with Modular Medical helps make that possible.” https://www.drugdeliverybusiness.com/modular-medical-unveils-next-gen-insulin-pump/ XX On Tuesday, 12 August 2025, Tandem Diabetes Care (NASDAQ:TNDM) presented at the Canaccord Genuity's 45th Annual Growth Conference, outlining strategic shifts and market focus. The company highlighted its plans for commercial transformation in the U.S. and expansion in international markets, alongside addressing competitive challenges and regulatory impacts. While optimistic about growth in Outside the U.S. (OUS) markets, Tandem is navigating a more competitive landscape domestically. We have entered into the pharmacy channel with Mobi only. And so as Mobi's been building up volume, we're getting experience and we're really learning and understanding what pharmacy offers to us. And the proof points have proved out the thesis I said earlier, which is it can really reduce that barrier for patients, is the out of pocket cost. And so we've decided to accelerate our strategy and where we were starting just with Mobi, we are now moving t slim supplies into the pharmacy channel, and that will kick into gear in the fourth quarter. So as people are looking at the cadence of sales for the remainder of the year with this reframing, many folks are seeing what looks like a a might be an outsized fourth quarter and and having trouble understanding those dynamics. We'll be adding the tSIM supplies to those contracts. We also have more coverage. We will have it in the coming weeks effective this year, so we will be increasing that 30% rate before the end of the year. And then, obviously, everyone's in the same cycle right now already negotiating and discussing their 2026 coverage. And so 30% is the floor.   We do expect to continue to grow that coverage in the coming years, and ultimately have a much broader access. Absolutely. It's an exciting technology that allows for us to have an infusion set that extends the wear time from three days to up to seven days. So we're able to use that as part of an independent infusion set, which would then be used with the t slim and with the mobi pump today. But we're also using that same technology as part of the site that's used for mobi when you use it with a tubeless cartridge. So next year, we will launch Mobi in a patch configuration.   It uses the same pump that's available today, but by using a modified cartridge, you're able to wear it as a patch pump. So one of the things we announced on the call is that we're using this extended wear technology as part of that site. So what it allows you to do is to change the portion that you wear in your skin separate from the timing of when you change the insulin cartridge. So it allows for that extended wear time, reduction of burden to the patient, which is especially important for higher volume insulin users as we expand into type two. So from here, we will launch the extended wear site next year along with we'll do a separate regulatory filing for the cartridge portion for Mobi that includes this extended wear technology as a predicate device. So that's another filing that we'll need to do, but we have the clearance today for the independent infusion set, but we'll file another five ten k for use of the extended wear technology as part of the tubeless Mobi feature. https://za.investing.com/news/transcripts/tandem-diabetes-at-canaccord-conference-strategic-shifts-and-market-focus-93CH-3834464 XX MannKind today announced a significant regulatory submission and a large financing agreement with Blackstone. The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said.   First, the Danbury, Connecticut-based company announced that it submitted a supplemental Biologics License Application (sBLA) for Afrezza, its inhaled insulin product, in the pediatric population.   MannKind Director of Medical and Scientific Engagement Joanne Rinker, MS, RDN, BC-ADM, CDCES, LDN, FADCES, told Drug Delivery Business News at ADA 2025 that a submission was on the way for children and adolescents aged 4-17 years old. Further data shared at ADA found Afrezza both safe and effective in that age range.   Afrezza is a fast-acting insulin formulation delivered through an inhaler device. MannKind engineered the mechanical inhaler device to slowly bring powder into the lung. A small compartment opens for the insertion of the insulin cartridge, then the user closes it. The only other component is a mouthpiece for the sake of cleanliness. Then, the inhalation takes just two seconds. It requires no electronics or extra components.   The company expects a review acceptance decision early in the fourth quarter of 2025.   “The submission of our supplemental Biologics License Application (sBLA) for Afrezza in pediatric patients is a meaningful milestone for MannKind and people living with diabetes,” said Michael Castagna, CEO of MannKind Corporation.   Additional funding provides a significant boost for MannKind MannKind also announced a strategic financing agreement with funds managed by Blackstone worth up to $500 million. The financing provides MannKind with non-dilutive capital to advance its short- and long-term growth strategies.   This senior secured credit facility includes a $75 million initial term loan funded at closing. It then has a $125 million delayed draw term loan available for the next 24 months. Finally, it features an additional $300 million uncommitted delayed draw term loan available at the mutual consent of MannKind and Blackstone.   The facility bears interest at a calculated SOFR variable rate plus 4.75% and matures in August 2030.   “This strategic financing significantly increases our operating flexibility and provides us substantial access to non-dilutive capital on favorable terms, complementing our strong cash position,” said Castagna. “The funding will support the expansion of our commercial team in preparation for the anticipated launch of the pediatric indication for Afrezza, if approved, continued pipeline advancement, potential business development opportunities, and general corporate purposes. Partnering with the Blackstone team on this transaction positions us to accelerate our next phase of growth and innovation.” https://www.drugdeliverybusiness.com/mannkind-fda-submission-pediatrics-500m-blackstone/ XX   Medtronic MiniMed Abbott Instinct Sensor [Image from Medtronic Diabetes on LinkedIn] The Medtronic Diabetes business today took to social media to share an early preview of a new integrated Abbott sensor for its insulin delivery systems. Medtronic Diabetes — soon to be MiniMed after its planned separation from the medtech giant – said in the post that the new sensor specifically designed for its own systems is called “Instinct.”   “Get a sneak peek at what's coming next: the Instinct sensor,” the business unit's account wrote. “Made by Abbott, the Instinct sensor is designed exclusively for MiniMed systems. We'll share more details about the Instinct sensor when it's commercially available.”   The sensor, built on the Abbott FreeStyle Libre platform, reflects “the power of the partnership,” Abbott EVP, Diabetes Care, Chris Scoggins, told Drug Delivery Business News earlier this year.   Medtronic and Abbott — two of the largest diabetes tech companies in the world — announced a year ago that they entered into a global partnership pairing Abbott continuous glucose monitors (CGMs) with Medtronic insulin delivery systems.   The partnership aims to collaborate on a system based on Abbott's FreeStyle Libre CGMs with Medtronic's automated insulin delivery technology (the latest generation being the MiniMed 780G) and smart insulin pen systems, such as the InPen system.   Read more about Medtronic, Abbott and the rest of the diabetes tech industry in our free Diabetes Technology Special Report. Medtronic's systems previously used its own CGMs, such as the Guardian 4 and the Simplera platform, and the company intends to continue using those systems as part of a comprehensive CGM portfolio. Under the companies' agreement, the systems would be sold exclusively by Medtronic — including the Abbott CGM.   The companies brought the partnership a step further in April when Medtronic announced the submission of an interoperable pump with the Abbott sensor technology to the FDA. They plan to share more details following the expected FDA clearance, which remains pending.   Management also recently emphasized the multi-year nature of the partnership, meaning Medtronic could pair current and future pumps with other Abbott sensors in the future. That could hint at integration with the company's future dual glucose-ketone monitor, as a number of pump makers have already announced collaborations to pair their systems with the sensor once it hits the market. https://www.drugdeliverybusiness.com/medtronic-diabetes-previews-abbott-sensor-minimed/ XX Governor Glenn Youngkin joined Civica officials at the company's Petersburg manufacturing facility to announce a $3 million grant from the Commonwealth of Virginia to accelerate Civica's efforts to develop and produce affordable insulin for Americans living with diabetes.   CivicaRx Logo   "We are proud to partner with Civica in their mission to make essential medicines more accessible," said Governor Youngkin. "This investment reflects our belief in the power of public-private collaboration to improve lives and strengthen communities."   These funds will support the production of insulin aspart, a rapid-acting human insulin analog used to regulate blood sugar in adults and children with diabetes. Civica plans to produce both rapid- and long-acting insulins at its state-of-the-art manufacturing facility in Petersburg, Va., where the company now employs more than 200 skilled workers.1 Over 8 million people living with diabetes need rapid-acting and/or long-acting insulin.   The Governor also announced that he had officially proclaimed August 7 – 14 2025 'Life Sciences Week' demonstrating the Commonwealth's commitment to "accelerating the advancement of the life sciences through public-private partnerships, STEM education, workforce development, and sustained investment in research and development."   "We are grateful for the Commonwealth's support," said Ned McCoy, Civica's President and CEO. "This funding will help us move closer toward our goal of ensuring that no one has to choose between insulin and other basic needs."   Civica and Virginia officials were joined by Lynn Starr, Chief Global Advocacy Officer of Breakthrough T1D, the leading global type 1 diabetes research and advocacy organization.   "More than one million American adults live with type 1 diabetes, and many still, sadly, ration their insulin, due to the prohibitively high cost of this necessary medication," said Starr.  "Civica's work will help to make insulin more affordable for people across the country."   Breakthrough T1D is among more than two dozen organizations and philanthropists, along with the states of Virginia and California, that have partnered with Civica to support the development of affordable insulins.   Civica's insulin initiative aims to provide patients with predictable, transparent pricing — no more than $30 per vial or $55 for a box of five pens — regardless of insurance status.   About Civica Civica is a nonprofit pharmaceutical company established to address drug shortages. It was founded by a group of U.S. health systems and philanthropies who, after more than a decade of chronic shortages, recognized that the market was not self-correcting and that a different approach is required. Civica works to deliver a safe, stable, and affordable supply of essential medicines to U.S. patients.   Media Contact: Liz Power liz.power@civicarx.org +1 860 501 3849 https://cbs4indy.com/business/press-releases/cision/20250807NY46213/governor-glenn-youngkin-announces-3-million-grant-to-support-civicas-affordable-insulin-programs/ XX If you or someone you love is living with diabetes, you already know the fight isn't just medical—it's financial, too. Between daily supplies, doctor visits, and long-term care, the cost of managing type 1 or type 2 diabetes can be overwhelming. Add college or trade school into the equation, and suddenly staying healthy competes with building a future. That's where scholarships for students with diabetes—like Beyond Scholars and others listed here—step in.   Whether you're headed to a university, a two-year college, or a hands-on trade program, these opportunities were created to ease the load.   Scholarships for students with diabetes Beyond Scholars (from Beyond Type 1): $10,000 for recently graduated high school seniors with type 1 diabetes or type 2 diabetes entering college or trade school. This is one of the largest needs-based diabetes scholarships in the United States. This year, awardees will also receive 6 months of wellness coaching through Risely Health.   Applications open: July 25, 2025 Deadline: August 29, 2025 Winners announced: October 2025 https://beyondtype1.org/beyond-scholars-diabetes-scholarships-college-trade-school/ XX Nick Jonas and Kyle Rudolph are using their platforms for a good cause.   On Tuesday, Aug. 12, the singer and the former NFL tight end (via his professional fundraising platform Alltroo) announced they're teaming up to launch a rally featuring a fan-coveted prize: a custom 2025 Volkswagen ID. Buzz electric bus that the Jonas Brothers have brought along for their 20th anniversary tour.   “Ten years ago, we hit the road with a goal to change what it means to live with diabetes. Since then, Beyond Type 1 has grown into the world's largest digital diabetes community, offering the tools, education, and peer support needed to not only survive but thrive with diabetes,” Jonas, who co-founded Beyond Type 1 (a nonprofit that advocates for those living with diabetes), says in a statement.     “We've challenged stigma, built community, provided life-saving resources, and collectively driven global innovation toward prevention and cure. This milestone is a moment to rally even more support for our mission, and partnering with Alltroo helps us do that in a powerful, engaging way.”   Related Stories Nick Jonas on Managing His Diabetes: 'The Mental and Emotional Health Aspect Is Really Important' nick jonas Nick Jonas Says He Was Diagnosed with Diabetes After Joe Told Their Parents: 'Something's Really Wrong' Joe Jonas and Nick Jonas attend the amfAR Cannes Gala 30th edition at Hotel du Cap-Eden-Roc on May 23, 2024 For Rudolph, the campaign is about "celebrating Beyond Type 1's incredible work over the past decade, and standing behind their vision of a world where everyone with diabetes — or at risk of it — has access to the knowledge, care and support needed for early diagnosis and lifelong health."   While the rally is live on Alltroo.com, fans can also scan QR codes available at all 36 Jonas Brothers concert stops to enter for a chance to win the electric bus. (A winner will be selected on November 14, which is World Diabetes Day.)   Jonas, 32, has long been open about his Type 1 diabetes diagnosis at 13 years old. "I had this kind of wrench thrown into things when I was diagnosed and it took a while to figure out how to count carbs to properly dose for insulin and what things would affect me in different ways," he previously told PEOPLE.   "When I was first diagnosed, I was sitting in the hospital and was scared to death, honestly, while I was learning about how to manage this new thing I was dealing with," Jonas recalled. "It would have been amazing to have someone to look at at that time to say, oh, this is a person living with it and they're following their dreams. They're doing what they want to do with their lives and not letting it slow them down."           https://people.com/nick-jonas-kyle-rudolph-launch-fan-rally-diabetes-awareness-11788684

Pre-diabetes marks the initial phase of diabetes. A fasting blood sugar level below 110 mg/dL is considered normal. If it ranges from 110 to 126 mg/dL, you are classified as pre-diabetic. The Oral Glucose Tolerance Test (OGTT) involves consuming 75 grams of glucose, followed by a blood sugar test two hours later. A result below 140 mg/dL is normal, while a range of 140 to 199 mg/dL indicates pre-diabetes. Additionally, HbA1c levels provide long-term insights into blood sugar control. Levels below 5.7% is normal, 5.7% to 6.4% indicate pre-diabetes, and 6.5% or higher signify diabetes. All people with diabetes cases progress through the pre-diabetes stage. World Diabetes Day and Awareness World Diabetes Day is celebrated on November 14th, coinciding with the birthday of Frederick Banting, the discoverer of insulin. This global initiative, led by the International Diabetes Federation, promotes awareness with an annual theme. The 2024–2026 theme focuses on Diabetes and Well-Being, and the 2024 sub-theme emphasizes Breaking Barriers, Bridging Gaps, highlighting the importance of a fulfilling life alongside managing diabetes. Gestational Diabetes and Pregnancy Hormones During pregnancy, placental hormones like human placental lactogen, (HPL), progesterone and estrogen increase insulin resistance by over 50%, impairing insulin's effectiveness. Typically, if someone's pancreas is producing about 50 units of insulin daily, during pregnancy, it may need 75–80 units per 24hr. If beta cells cannot meet this increased demand of pregnancy, blood sugar levels rises, leading to gestational diabetes. A glucose challenge test with 75 grams of glucose, followed by a blood sugar measurement after two hours, acts as a stress test for beta cell function. Levels below 140 mg/dL are normal, while levels above 140 indicate gestational diabetes. Early detection and management are crucial to ensure a healthy baby's birth. Recorded on: 8.11.2024 Recorded at: Akashwani Nagpur

Students and teachers at The Des Barra Primary School marked World Diabetes Day with a Mini Health Fair organized by the Ministry of Health, Wellness, and Elderly Affairs. The event focused on raising awareness about diabetes prevention and management while promoting healthier lifestyle choices among the youth. Health officials led an interactive program featuring educational sessions, hands-on activities, and a lively exercise session.  

Ahead of World Diabetes Day on Nov 14th Episode 2 of Dr. Eva's Life in Balance features people who have reversed their Type 2 Diabetes. Eva also talks about how to find Love with the founder of the Two's Company Dating Agency - Jennifer Haskins. Co-hosted by Sylvia Ferguson, Dr. Eva's new radio show may help you get your Life in Balance. Originally broadcast on SBCR on 9th November 2024

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: World Diabetes Day roundup, existing drugs examined for T1D prevention, Blue Circle Health expands its novel T1D care model, Mounjaro studied further, Canada approves a new pumps system, and tragedy in the diabetes community.  Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Of course, World Diabetes Day was yesterday. November 14 marks the birthday of Sir Frederick Banting. who discovered insulin along with Charles Best in 1922. Lots of the tech companies are taking action.. I'm going to link up a great article highlighting what many of them are doing…. from Medtronics Blue Balloon challenge to Dexcom's Nick Jonas video and a lot more. https://www.drugdeliverybusiness.com/world-diabetes-day-2024/ XX A new triple combo therapy could restore insulin production in people with type 1 using existing medications. Levicure's triple-combo oral therapy is already considered very safe, because it involves two drugs approved by the U.S. Food and Drug Administration (FDA) and a well-known supplement. The therapy is a combination of: DPP4-inhibitors, a common type 2 diabetes medication Proton pump inhibitors (PPIs), a drug for severe acid reflux A proprietary version of gamma-aminobutyric acid (GABA), a supplement often used to treat anxiety Levicure says the combined effect can block beta cell destruction, suppress autoimmunity, and restore beta cell function. So far, Levicure's triple therapy has gone through only one retrospective chart review; it has not been put to the test in a randomized controlled trial https://www.diabetesdaily.com/blog/can-this-triple-combo-oral-therapy-restore-insulin-production-733261/   XX Blue Circle Health is expanding it's unique approach to type 1 care. Already active in Florida, Maine & Vermont, it will now be in Delaware and Ohio. Blue Circle Health is free and develops a personalized care plan for each participant, tailored to their unique needs, and offers comprehensive multidisciplinary support over a six-month period. It's paid for by the Helmsley Charitable Trust. The program is available to people 18 years of age and older that speak Spanish or English, regardless of insurance coverage or citizen status. We've got an upcoming podcast episode all about Blue Circle coming up soon. https://www.prnewswire.com/news-releases/blue-circle-health-expands-to-delaware-and-ohio-to-address-health-system-barriers-to-type-1-diabetes-care-and-education-302304170.html XX An international team of experts has created the world's first evidence-based guide for eating lower and low carb. The group says until now, people with type 1 diabetes and their healthcare providers have lacked comprehensive resources to help implement this approach safely and effectively. The guide provides essential information for dietitians and nutritionists and empowers them to work collaboratively with individuals and families who are interested in reducing carbohydrates. It's free and we've got the download link in the show notes. https://www.newswire.ca/news-releases/international-team-launches-first-guide-for-carbohydrate-reduction-in-type-1-diabetes-883729104.html XX A new pump system is available in Canada. mylife YpsoPump insulin pump and CamAPS FX hybrid closed-loop algorithm by Health Canada. mylife Loop consists of the mylife YpsoPump, a lightweight intuitive insulin pump, integrated with the CamAPS FX hybrid closed-loop, a mobile phone-based algorithm, and the Dexcom G6 Continuous Glucose Monitoring (CGM) System. Working together, these components provide an innovative, automated insulin delivery (AID) system designed to simplify insulin therapy and improve glycemic control for Canadians living with diabetes.   "The approval of the mylife YpsoPump and CamAPS FX marks an important milestone as we bring these advanced technologies to the Canadian market," said Sébastien Delarive, Chief Business Officer of Ypsomed Diabetes Care. "Although Ypsomed is relatively new in Canada, our established leadership in diabetes care throughout Europe provides a solid foundation for delivering innovative solutions to Canadians living with type 1 diabetes."   "We are excited to see both mylife YpsoPump and CamAPS FX approved," said Karina Schneider, General Manager at Ypsomed Canada. "This step brings us closer to offering an integrated solution that will help simplify diabetes management for Canadian patients, empowering them to take more control of their health." https://finance.yahoo.com/news/ypsomed-camdiab-receive-health-canada-205500840.html XX The FDA updates the labels for all GLP-1 receptor agonists with a warning about pulmonary aspiration during general anesthesia or deep sedation. The affected drugs are semaglutide (Ozempic, Rybelsus, Wegovy); liraglutide (Saxenda, Victoza); and the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 tirzepatide (Mounjaro, Zepbound). the Medication Guide section of the label also has new additions. Patients are counseled to tell their healthcare provider if they are scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation). They are alerted that the GLP-1 RAs they are taking may cause serious side effects, including food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sedation. Patients are advised to tell all their healthcare providers that they are taking a GLP-1 RA before they are scheduled to have surgery or other procedures. https://www.medscape.com/viewarticle/fda-updates-glp-1-label-pulmonary-aspiration-warning-2024a1000k84?form=fpf XX Following an impressive data drop this summer highlighting the potential for Eli Lilly's tirzepatide to stave off progression to Type 2 diabetes in prediabetic patients, the Indianapolis-based drugmaker is laying out full results from its longest completed study of the dual GIP/GLP-1 receptor agonist to date. In the three-year SURMOUNT-1 trial, tirzepatide curbed the risk of disease progression to Type 2 diabetes by 94% versus placebo in adult prediabetes patients who were obese or overweight, Lilly said in a release Wednesday. The number represents a pooled result from three tirzepatide doses (5 mg, 10 mg and 15 mg) studied in the trial.   Putting those results into perspective, one new case of diabetes could be prevented for every nine patients treated with tirzepatide, which is marketed in the U.S. as Mounjaro for Type 2 diabetes and as Zepbound for obesity, Lilly said. https://www.fiercepharma.com/pharma/lilly-unwraps-detailed-data-showing-tirzepatide-kept-nearly-99-pre-diabetic-patients XX Edgparke commeical? XX https://www.bloomberg.com/news/articles/2024-10-25/apple-secretly-tests-blood-sugar-app-in-sign-of-health-ambitions XX XX And finally, many of you have likely already heard but we had some incredibly tragic news in the diabetes community, especially for the Breakthrough T1D ride community. I'm going to read from the Breakthrough T1D website: The leadership, staff, and volunteers of Breakthrough T1D mourn the tragic, sudden loss of five T1D Champions on Friday, Nov. 1, 2024.  Jeff and Michelle Bauer, Josh and Tammy Stahl and Barry Sievers were all killed in a singe car crash. The group included two married couples and one single individual—all very close friends and veteran Breakthrough T1D Ride participants. Of this incredibly impactful group, I knew Michelle Bauer personally, I met her as Michelle Alswager – you may know her as Jesse's mom. Her son, Jesse died from complications of type 1 in 2010. And that year, mile 23 on the JDRF ride was created as a mile of silence in memory of Jesse.  Now all riders are asked to ride in silence for that mile not only in memory of Jesse, but all those lost to type 1 diabetes. Michelle wrote her book, Jesse Was Here and created a program that's part of Beyond Type 1 to this day, all to help other families going through grief. She called me a few years ago when she was thinking of writing her book and I'm so grateful for our conversations and that our conversations may have helped her get it out there into a world where it's so needed. But we need Michelle here to talk about grief. More about talking to Michelle about the book).   Please, write the book, ride the bike, do the ironman, follow your heart and your dreams.  All of these incredible people gone too soon. https://www.breakthrought1d.org/news-and-updates/breakthrough-t1d-mourns-tragic-sudden-loss-of-five-ride-champions/   Thanks for joining me..

Hope and Progress in Type 1 Diabetes Management In honor of World Diabetes Day earlier this week, this podcast episode celebrates the strength of our T1D Moonshot Community and explores innovative solutions for better insulin delivery management. This episode features inspiring conversations with: Ole Kjerkegaard Nielsen, PhD, CEO & Co-founder of GO-Pen: Making insulin pens more affordable and accessible Bill Ervin, CEO & Founder of Bulsai: Revolutionizing injection techniques for optimized results Discover how these groundbreaking ventures are: Empowering patients with better tools and technology Addressing key frustrations in current diabetes management Plus, learn about StartUp Health's Health Moonshot Communities, like the T1D Moonshot Community, and how they connect founders tackling the biggest health challenges, such as Type 1 diabetes. This episode is a must-listen for anyone impacted by Type 1 diabetes, healthcare professionals, and innovators passionate about improving patient lives. Listen now and join the movement for a brighter future! Are you ready to tell your story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world's biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of StartUp Health's PRO Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you're mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Nosipho Radebe speaks to Stavros Nicolau, Senior Executive for Strategic Trade at Aspen PharmacareSee omnystudio.com/listener for privacy information.

Welcome all to IS PHARMACOLOGY DIFFICULT Podcast! I am Dr Radhika VijayIn today's bonus episode, I will talk about recent and current updates and advances of the Pharmacological drugs and therapies used in the management of Diabetes.Wishing all great knowledge, cure, awareness and happiness on this WORLS DIABETES DAY 2024!!DRUGS MENTIONED IN THE PODCAST:1. Metformin2. Continuous Glucose Monitoring Systems (CGM)3. Insulin Infusions4. Sodium Glucose Cotransport 2 Inhibitors (SGLT2 Inhibitors)5. Tzield (Teplizumab-mzwv) antibody6. VX-880 stem cell therapy7. Lantidra8. Mounjaro (Tirzepatide)9. Cagrilinitide-Semaglutide (Cagri-Sema)10. Retatrutide11. OrforglipronMy podcast is featured in "BEST SCIENCE PODCASTS"- Check the link here:https://podcasts.feedspot.com/india_science_podcasts/My podcast is featured in "BEST INDIAN MEDICAL PODCASTS". Check the link here:https://podcasts.feedspot.com/india_medical_podcasts/?feedid=5503395For all the updates and latest episodes of my podcast, please visit www.ispharmacologydifficult.com where you can also sign up for a free monthly newsletter of mine."Pharmacology Further" E-Newsletter and Podcast:The links for these are at all my websites and specifically:Link for E-Newsletter: https://pharmacologyfurther.substack.com/Link for the E-Newsletter Podcast: https://www.pharmacologyfurther.comIt actually contains lot of updates about the medical sciences, drug information and my podcast updates also.You can follow me on different social media handles like twitter, insta, facebook and linkedin. They all are with same name "IS PHARMACOLOGY DIFFICULT". If you are listening for the first time, do follow me here, whatever platform you are consuming this episode, stay tuned, do rate and review on ITunes, Apple podcasts, stay safe, stay happy, stay enlightened, Thank you!!Please leave Review on Apple podcasts!My E-Newsletter sign up at Substack!Connect on Twitter & Instagram!My books on Amazon & Goodreads!

Welcome all to IS PHARMACOLOGY DIFFICULT Podcast! I am Dr Radhika VijayIn today's bonus episode, I will talk about recent and current updates and advances of the Pharmacological drugs and therapies used in the management of Diabetes.Wishing all great knowledge, cure, awareness and happiness on this WORLS DIABETES DAY 2024!!DRUGS MENTIONED IN THE PODCAST:1. Metformin2. Continuous Glucose Monitoring Systems (CGM)3. Insulin Infusions4. Sodium Glucose Cotransport 2 Inhibitors (SGLT2 Inhibitors)5. Tzield (Teplizumab-mzwv) antibody6. VX-880 stem cell therapy7. Lantidra8. Mounjaro (Tirzepatide)9. Cagrilinitide-Semaglutide (Cagri-Sema)10. Retatrutide11. OrforglipronMy podcast is featured in "BEST SCIENCE PODCASTS"- Check the link here:https://podcasts.feedspot.com/india_science_podcasts/My podcast is featured in "BEST INDIAN MEDICAL PODCASTS". Check the link here:https://podcasts.feedspot.com/india_medical_podcasts/?feedid=5503395For all the updates and latest episodes of my podcast, please visit www.ispharmacologydifficult.com where you can also sign up for a free monthly newsletter of mine."Pharmacology Further" E-Newsletter and Podcast:The links for these are at all my websites and specifically:Link for E-Newsletter: https://pharmacologyfurther.substack.com/Link for the E-Newsletter Podcast: https://www.pharmacologyfurther.comIt actually contains lot of updates about the medical sciences, drug information and my podcast updates also.You can follow me on different social media handles like twitter, insta, facebook and linkedin. They all are with same name "IS PHARMACOLOGY DIFFICULT". If you are listening for the first time, do follow me here, whatever platform you are consuming this episode, stay tuned, do rate and review on ITunes, Apple podcasts, stay safe, stay happy, stay enlightened, Thank you!! Please leave Review on Apple podcasts! My E-Newsletter sign up at Substack! Connect on Twitter & Instagram! My books on Amazon & Goodreads!

The number of adults living with diabetes worldwide has exceeded 800 million, more than quadrupling since 1990. This is according to new data published in the journal The Lancet on World Diabetes Day.Also on the programme: Police in Brazil say an attack on the Supreme Court was a terrorist incident; and there is growing anger over Donald Trump's choices for some of the most powerful positions in the next US government, particularly his choice of Attorney General.(Photo: A person using a set of weighing scales. Credit: PA)

The realities of living with type one as a child in the UAE.See omnystudio.com/listener for privacy information.

World Diabetes Month, observed every November, is a global campaign aimed at raising awareness about diabetes and its impact on individuals and communities worldwide. Organized by the International Diabetes Federation (IDF), this month-long initiative seeks to educate the public on the prevention, management, and treatment of diabetes, while also advocating for better healthcare policies and support systems for those living with the condition. Today is also recognized as World Diabetes Day, so we thought it fitting to engage endocrinologist, Dr. Ariane Davis-Simmons and director of weight loss solutions here at Doctors Hospital, Dr. Janette Martin. Listen in as we have a riveting conversation on the disease, statistics in The Bahamas, the need for support and steps for management. Share & Subscribe #diabetesawareness #worlddiabetesday

PJ talks to Paloma about discovering she has Diabetes and to Charlotte Pearson of Diabetes Ireland as we mark World Diabetes Day. Hosted on Acast. See acast.com/privacy for more information.

Today is World Diabetes Day. Diabetes and well-being is the theme for World Diabetes Day. This evening, an event for those with Type 1 diabetes will be held in Ennis from 7:30pm to 9:30pm. To discuss her experience and more, Alan Morrissey was joined in-studio by Co-founder of Thriveabetes, Gráinne Flynn who is also a volunteer with Diabetes Ireland. Photo (c): Clare FM

World Diabetes Day: Raising awareness in the Eastern Cape with health screenings by Radio Islam

On Thursday morning, East Coast Breakfast marked World Diabetes Day with a special guest, Dr. Steph Osborn, an expert in hyperbaric oxygen therapy. Dr. Osborn joined us to answer listener questions about diabetes, including if it's curable, and what symptoms to look out for. She also shared insights into how hyperbaric oxygen therapy can support diabetes management. Listen to the full conversation on the podcast at ecr.co.za, just select East Coast Breakfast! Webpage

Diabetes is a serious condition that affects millions worldwide and, in Nigeria, it is becoming increasingly prevalent. For individuals whose parents or close family members have diabetes, the risk of developing the disease can be significantly higher. But is there hope for prevention? Can the cycle be broken?Join us on this episode of Nigeria Daily as we try to find answers to these questions.

Resident film reviewer Ben O'Shea joins Clairsy  & Lisa to spill all the details on the highly anticipated sequel, Gladiator 2. In The Shaw Report, Lisa gives us details on the big megamix set to come out later this year to mark 40 years since Band Aid's ‘Do They Know It's Christmas?' Miguel Maestre calls in to share his healthy meal tip raising awareness for World Diabetes Day. We ask how long have you had your car?... And we continue Story Behind The Song by hearing all about ‘Tiny Dancer' by Elton John.See omnystudio.com/listener for privacy information.

Miguel Maestre joins Clairsy and Lisa on the show to talk about World Diabetes Day to raise awareness, and how he has made his flavourful meals healthy for the whole family.See omnystudio.com/listener for privacy information.

Today is World Diabetes Day. While lifestyle changes are the foundation of treating and managing Type 2 diabetes, whole-food plant-based diets and indigenous foods are now being recognized to significantly improve symptoms and quality of life. So, is a plant-based diet for diabetes a good idea? Prof Xikombiso Mbhenyane, Research Chair in Food Environment, Nutrition & Health weighs in now.See omnystudio.com/listener for privacy information.

Popular Durban General Practitioner Dr Devarshni Reddy joins Carol Ofori in studio to talk all things diabetes on World Diabetes Day.

Today is World Diabetes Day. Diabetes is THE number 1 killer of women in South Africa and the 2nd leading cause of death amongst men in South Africa. This is not a fatal illness but one that can easily be managed with the right knowledge and assistance. Diabetes community support NPO Sweetlife aims to motivate everyone in South Africa to wear Blue for diabetes and ensure that everyone knows the 5 symptoms of diabetes to ensure they can assistance as quickly as possible. Siyabonga Kwanele Zuma, diabetes activist explains more.   See omnystudio.com/listener for privacy information.

50% of millennials think they're headed for one - but 81% can't afford it!See omnystudio.com/listener for privacy information.

In honor of World Diabetes Day on November 14, we are sharing a bit of knowledge about a silent killer that affects more than 38 million Americans. What is it, what causes it, and what can we do to treat it? 

In her mid-20s and thriving in a fast-paced communications job, Mila Clarke began experiencing symptoms reminiscent of those her mom had managed with diabetes for years. However, as time went on, it became clear that this was different. Little did she know, her life was about to take a significant turn, leading her on an unexpected journey with a chronic illness she never saw coming.Support the show: https://www.steveharveyfm.com/See omnystudio.com/listener for privacy information.

Tami Harker and Keri Bloom joined Samantha Rux on Wake Up Tri-Counties to discuss Diabetes Awareness.  November is Diabetes Awareness Month and November 14th is World Diabetes Day. 

In this episode, we dive deep into the emotional side of diabetes, exploring how well-being plays a vital role in managing type 2 diabetes and prediabetes. With 36% of people experiencing diabetes distress and 63% living in fear of complications, it's clear that the mental and emotional toll of diabetes is just as significant as the physical aspects. You'll learn practical strategies to manage these challenges, improve your emotional health, and take small steps to prioritize your overall well-being.We also discuss powerful tools like future pacing—a mindset technique that helps you visualize your healthier, future self and use that vision to stay motivated and take positive action today. Whether you're newly diagnosed or have been managing diabetes for years, this episode will offer you support, encouragement, and real-world steps to help you thrive, not just survive, with diabetes.CHAPTERS1:14 Share diabetes awareness with others2:00 World Diabetes Day 2024 theme4:02 Dimensions of well-being6:06 Understanding diabetes distress8:08 Overcoming fear of complications11:32 Building a thrive mindset13:07 Future pacing to create better health and well-being18:29 Take care of your well-being each dayFor show notes and resources, please visit: https://Type2DiabetesTalk.comTo share your questions and suggestions, leave us a voice message or email at: https://Type2DiabetesTalk.com/messageExplore our proven programs and services, visit: https://Type2DiabetesTalk.com/programsSubscribe to our free weekly newsletter for podcast updates, valuable nutrition tips and more: https://Type2DiabetesTalk.com/subscribe

In today's episode, in honor of World Diabetes Day, we're diving deep into diabetes. Did you know that one in two people in the United States have either prediabetes or diabetes? This means that even if you don't have diabetes, someone you love probably does. Today, we break down what diabetes is, the differences between type 1 and type 2, whether prediabetes and diabetes are reversible, and most importantly, why having diabetes should never be a source of shame. We're joined by the two lovely ladies from the Diabetes Digital Podcast, and if you have more questions, you can find additional information on their website.For weekly episodes, come join the Foodie Fam!https://www.patreon.com/FWNTTTo get a summary of everything we talked about today, sign up for our email list. Check out our book:https://read.macmillan.com/lp/food-we-need-to-talk/Chat with us on IG!https://www.instagram.com/foodweneedtotalk/?hl=enBe friends with Juna on IG and Tiktok!https://www.instagram.com/theofficialjuna/https://www.tiktok.com/@junagjata

In this special episode, we sit down with Dr. Jackie Kassouf Maalouf, founder of DiaLeb to commemorate World Diabetes Day. DiaLeb is the National Diabetes Organization. It was founded in 2011 as a non-profit organization in Lebanon to promote diabetes care and prevention and help find a cure for this disease.  We explore the impact of diabetes on communities in Lebanon before and after the economic crisis and we discuss the importance of lifestyle modification as a preventative measure for type 2 diabetes. We also discuss the multiple projects that DiaLeb has been involved in promoting exercise and nutrition, and helping provide needed medications to people suffering from diabetes in Lebanon.  Tune in for this enlightening conversation which was recorded before the current war in Lebanon, but which provides hope for a bright future in Lebanon.  This episode is also available on Youtube: https://youtu.be/4hFBDbH0gJk and on all podcast apps.  #Diabetescare #Worlddiabetesday #diabetes #diabetesprevention #lifestyle

This is a bitesize episode of 'The insuleoin Podcast - Redefining Diabetes'. Each week we'll take a look back into the archive of episodes and get you to think and reflective once more about some of the things we've learned over the past few years. In this week's BITESIZE:Raising your own awareness for your own diabetes. Identify things that give you energy and dilute your energy. Doing the small things consistently. To hear the full episode check out episode #141: Bursting Through a Trampoline & Breaking Both Legs, World Diabetes Day! Hosted on Acast. See acast.com/privacy for more information.

WORLD DIABETES DAY 2024 --- Send in a voice message: https://podcasters.spotify.com/pod/show/keshagenadderleypodcast/message

"The doctor said: 'You need to put your phone down because we have to get this drip into your arm, otherwise you're going to die.' And that was my introduction to type 1 diabetes."Today's guest is Harriet Minter - published author, journalist, coach and gender equality specialist.Harriet has worked and written for among others, The Guardian, The Times and the Telegraph. She's a columnist for Psychologies magazine, and created the wildly successful Badass Women's Hour podcast and live radio show, which she was very much in the throes of when she received that terrfying type 1 diabetes diagnosis on World Diabetes Day 2020, at the age of 38.That horrifying diagnosis was in the midst of the pandemic, and it has since altered Harriet's relationships with her work, her loved ones, and ultimately herself.Wise, sharp and insightful, this is an incredibly thought-provoking chat, covering the vulnerability that diabetes forces you to face, the conflict of becoming both more independent and more willing to ask for help, accepting her body's limits, stigma around body size and diabetes, diabetes in the workplace and my favourite new phrase - SOFT POWER. Oh, and don't speak to Harriet about glucose monitoring as a health trend...This was such a treat to record, I hope you enjoy it! Be sure to check out Harriet's writing on her Substack too - aptly titled We Can't Do It Alone. CONNECT WITH HARRIETSubscribe to Harriet's Substack.Follow Harriet on Instagram.JOIN THE TYPE 1 ON 1 INSTAGRAM COMMUNITYWe've got an Instagram account! Come and say hi @studiotype1on1 SPONSOR MESSAGEThanks to my episode sponsors Insulet, the founders of Pod Therapy - only found with Omnipod. Pod Therapy uses a tubeless, wearable and waterproof Pod that continuously delivers insulin for up to three days. Controlled wirelessly by its handheld companion, it allows you to personalise your insulin doses according to your own daily needs - no multiple daily injections and no tubes. Head to https://www.omnipod.com/ to find out more.

In this episode of Diabetics Doing Things, sponsored by Medtronic, Rob is joined by Monique La Bomme, in an episode recorded live on World Diabetes Day at the Medtronic Diabetes headquarters in California. Monique shares her experience of living with type 1 diabetes and discusses her journey with diabetes alert dogs and diabetes management technology. The conversation also delves into the importance of representation and advocacy in the diabetes community. Topics discussed: 1. Monique's diagnosis story and early days with diabetes 2. Diabetes management, technology, and the use of diabetes alert dogs 3. Representation and advocacy in the diabetes community 4. The impact of diabetic alert dogs on people's lives 5. Balancing diabetes management and social life as an actor and model Here are key takeaways and lessons: - Monique shares her diagnosis story, highlighting the importance of early detection and the role of a lung specialist in her diagnosis. - Her positive experience with diabetes management at a children's hospital and the supportive diabetes community during her early days with diabetes. - The significance of diabetes alert dogs in detecting glucose changes and preventing severe hypoglycemia incidents. - The importance of representation and advocacy in the diabetes community, especially in showcasing diverse experiences and stories. - The impact of diabetic alert dogs on raising awareness and inspiring others to consider using service dogs for diabetes management. References: - Instagram handle: Monique La Bomme - [@moniquenicolee] (https://www.instagram.com/moniquenicolee/) - Medtronic - [Medtronic Diabetes](https://www.medtronicdiabetes.com/) - World Diabetes Day - [International Diabetes Federation](https://www.idf.org/our-activities/world-diabetes-day.html) 00:00  Live from Medtronic HQ: A Type 1 Diabetes Journey on World Diabetes Day 05:09  Navigating Type 1 Diabetes: Community Support and Advanced Technology 09:40  How a Diabetic Alert Dog Changed My Life: Monique's Story 19:33  Breaking Barriers: Advocating for Diversity and Inclusivity in the Diabetes Community

Join Prof. Francesco Giorgino and Dr. Alice Cheng for a discussion on the importance of being culturally sensitive during shared decision-making in type 2 diabetes care. For more free education, go to ⁠⁠diabetes.knowledgeintopractice.com⁠⁠⁠, where you can see all past episodes of the podcast as well as other free CME resources. Follow us on Twitter (⁠⁠@dkipractice⁠⁠⁠) or connect on ⁠⁠LinkedIn⁠⁠⁠. Faculty disclosures Prof. Francesco Giorgino Grants or contracts: Eli Lilly, Roche Diabetes Care Consulting: Eli Lilly, Novo Nordisk Honoraria for lectures, presentations and education events: Astra-Zeneca, Boehringer-Ingelheim Advisory boards: Eli Lilly, Lifescan, Merck Sharp & Dohme, Medimmune Leadership or fiduciary role in other board: EASD/EFSD, (SIE), Fo.Ri SIE Receipt of equipment, materials, drugs, medical writing, gifts or other services: AstraZeneca, Eli Lilly, Novo Nordisk Unlabelled use of drugs or devices: Roche Diabetes Care, Sanofi Dr. Alice Cheng Advisory Board: Abbott, AstraZeneca, Bayer Speakers Bureau: Abbott, Amgen, AstraZeneca, Bausch, Bayer Funding Information: This independent educational activity is supported by an educational grant from Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Novo Nordisk A/S, has had no influence on the content of this education. Accreditation information Liberum IME staff, ACHL staff and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose. ACHL requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships within 24 months (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any ineligible companies. All relevant financial relationships have been mitigated prior to this activity. This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers' prescribing information for these products. ACHL requires its speakers to disclose that a product is not labeled for the use under discussion. Discussion of Off-Label, Investigational, or Experimental Drug Use: None

We in India celebrate 14th November as Children's Day, which is the birthday of the 1st Prime Minister of India Shri Jawaharlal Nehru. Similarly, World Diabetes Day is celebrated on the same date to mark the birthday of Dr. Fredrick Banting who discovered insulin along with Charles Best in 1921, for the treatment of diabetes. In January 1922, Leonard Thompson, a 14-year-old boy became the first human being to receive insulin injection. Millions of people with diabetes around the world do not have access to diabetes care. People with diabetes require ongoing care and support to manage their condition and avoid complications. Thus, the theme for World Diabetes Day for the year 2021-23 is Access to Diabetes Care. The focus is to provide people with diabetes the importance of having access to the right information and care to ensure better treatment and management. Dr. Kavita Gupta highlighted about how to celebrate your Diwali in a healthy way. She discussed on alternatives to simple sugars, fried items, transfat, portion control and mindful eating. Let us listen to the podcast……! Broadcasted on 10.11.2023

Meet Simone Carniglia, Six-Star finisher, and Guinness World Record holder as the fastest runner with Type One diabetes—with an amazing average time of 2:42:30 per race! Simone started his running journey to lose weight and was inspired by Stefano Baldini, the great Italian marathoner who won the gold medal at the 2004 Athens Olympics. Running these incredibly fast times is impressive, but for a diabetic, it is significantly more challenging. A diabetic marathoner has to continuously control blood sugar levels in order to be safe, not faint, and perform at their best. They're more subject to cramping and dehydration during physical activity, especially when glucose levels aren't managed properly. Simone has only been running for five years and is just getting started. He hopes his journey will inspire many other diabetic athletes to not give up on their dreams and never give up. Simone's story proves that with the right training, nutrition, therapy, strategy, and use of the latest technologies—such as Abbott Global and Freestyle Libre 3—diabetic runners can achieve amazing results that weren't imaginable just a few short years ago Simone is grateful for the Abbott Global profile they featured on him for World Diabetes Day and is excited to get started on a second round of World Marathon Majors. I'm rooting for Simone to keep inspiring and look forward to seeing him out there in 2024! If you enjoy the episode, it would mean the world to me if you would rate the podcast or write a review and share feedback wherever you get your podcast groove on. Connect With Simone: Instagram: https://www.instagram.com/simone.carniglia All Other Links: https://linktr.ee/6majorswitht1d Connect With Ron: Personal Instagram: https://www.instagram.com/ronrunsnyc Podcast Instagram: https://www.instagram.com/runchats_with_ronrunsnyc Facebook: https://fb.me/runchats Website: https://ronrunsnyc.com ---- Produced by: David Margittai | In Post Media Website: https://www.inpostmedia.com Email: david@inpostmedia.com Social: https://www.instagram.com/_margittai © 2023 Ron Romano

Context of White Supremacy hosts the weekly Compensatory Call-In. We encourage non-white listeners to dial in with their codified concepts, new terms, observations, research findings, workplace problems or triumphs, and/or suggestions on how best to Replace White Supremacy With Justice ASAP. This weekly broadcast examines current events from across the globe to learn what's happening in all areas of people activity. We cultivate Counter-Racist Media Literacy by scrutinizing journalists' word choices and using logic to deconstruct what is reported as "news." We'll use these sessions to hone our use of terms as tools to reveal truth, neutralize Racists/White people. #ANTIBLACKNESS The St. Louis International Film Festival had a wealth of documentaries at this year's event. One of them was, We Are Distance Runners: The Marathon Hat Trick - which details black female and male marathon runners who travel the planet to compete against White people in foot races. Tony Reed and Lisa Davis each said a part of the influence for their running is that they both had attempted black family members suffer greatly from diabetes. Unbeknownst to Gus, earlier this week, many people recognized World Diabetes Day. Dr. Frances Cress Welsing told us that black people do not qualify for mental health. Given the toxic plantation Racists force black people to uphold, it's no surprise that black people around the world are burdened with poor diets and the accompanying maladies like diabetes. #NoProcessedWhiteSugar #TheCOWS14Years INVEST in The COWS – http://paypal.me/TheCOWS Cash App: https://cash.app/$TheCOWS CALL IN NUMBER: 605.313.5164 CODE: 564943#

It's In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: Novo Nordisk will discontinue Levemir by the end of 2024, Tandem begins limited launch of software updates that will include Dexcom's G7, Beta Bionics iLet pump will be covered until some pharmacy plans, and lots more! Links and transcript below Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Take Control with Afrezza  Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX In the news is brought to you by Edgepark simplify your diabetes journey with Edgepark XX This week was World Diabetes Day so there is a LOT going on.. Our top story is XX Novo Nordisk said on Wednesday it would discontinue its long-acting insulin Levemir in the United States, citing manufacturing constraints, reduced patient access and available alternatives. The Danish drugmaker said supply disruptions would start in mid-January, followed by discontinuation of the Levemir injection pen in April and of Levemir vials by the end of 2024. Novo has another long-acting insulin, Tresiba, on the market and says quote - "global manufacturing constraints, significant formulary losses impacting patient access effective in January 2024, and the availability of alternative options in the U.S. market" are key factors in the decision. The announcement comes eight months after Novo said it would cut U.S. list prices for several of its insulin products next year, including a 65% reduction in the list price of Levemir. Novo, which overtook LVMH (LVMH.PA) as Europe's most valuable listed company this year, posted record operating profit for the third quarter, with sales of its obesity drug Wegovy reaching $1.36 billion, up 28% from the previous quarter. https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-discontinue-levemir-insulin-us-market-2023-11-08/ XX Big news from Tandem Diabetes this week – first, their Control IQ algorithm gets FDA approval for children as young as two years old. the technology's original 2019 clearance limited its use to those aged 6 and older. And.. they are officially rolling out the software update that will allow users to connect to either the Dexcom G6 or G7 CGM. If you're in the limited launch you got an email this week telling you the next steps – wider release is expected gradually in the first part of 2024. Integration with Abbot's FreeStyle Libre is expected very soon as well – which would mean Tandem's tslim x2 and Mobi pumps would be compatible with three CGMs. Full disclosure: there wasn't a media release that I received on this, but my son is in the limited launch group so we got the email.   https://www.fiercebiotech.com/medtech/tandem-diabetes-care-cruises-fda-ok-toddler-use-automated-insulin-delivery-algorithm XX Beta Bionics iLet pump and its supplies are now covered as part of some pharmacy benefits - Express Scripts added it to its national formulary list. Historically, insulin pumps fall under the durable medical equipment (DME) insurance benefit. Usually pharmacy benefits are more flexible with fewer up front costs. The system uses an adaptive, closed-loop algorithm that initializes with the user's body weight and requires no additional insulin dosing parameters. The algorithm removes the need to manually adjust insulin pump therapy settings and variables. iLet simplifies mealtime use by replacing conventional carb counting with its meal announcement feature. This enables users to estimate the amount of carbs in their meal, categorized as “small,” “medium” or “large.” Over time, the algorithm learns to respond to users' individual insulin needs. https://www.drugdeliverybusiness.com/beta-bionics-pharmacy-benefit-bionic-pancreas/ XX The UK has launched a pioneering study to explore the development of type 1 diabetes in adults which aims to screen 20,000 individuals. Research will enable earlier and safer diagnosis of type 1 diabetes through blood tests. This makes the UK the first country to implement general population screening for type 1 diabetes in both children and adults. The Type 1 Diabetes Risk in Adults (T1DRA) study, launched on World Diabetes Day, seeks to enroll 20,000 adults aged 18 to 70. Supported by The Leona M. and Harry B. Helmsley Charitable Trust and building on the Diabetes UK-funded Bart's Oxford Family study (BOX), T1DRA aims to unravel the mysteries of adult-onset type 1 diabetes. https://www.diabetes.co.uk/news/2023/nov/groundbreaking-study-to-screen-20000-adults-for-type-1-diabetes.html XX The National Institute for Health and Care Excellence (NICE), England's cost-effectiveness watchdog, has finalized a draft guidance regarding hybrid closed-loop systems, concluding that the technology should be made broadly affordable and accessible to help people with Type 1 diabetes better manage the condition. In this month's final draft guidance (PDF), NICE recommended that hybrid closed-loop technology be offered to all people with Type 1 diabetes who are having trouble controlling the condition using their existing devices.   NICE said that it has already devised a five-year rollout plan with the NHS to bring the technology to people with Type 1 diabetes. Hybrid closed-loop systems will be offered first to children, young people, existing insulin pump users and women who are pregnant or planning to become pregnant, after which they'll be issued to adults who have an average HbA1c reading of at least 7.5%. https://www.fiercebiotech.com/medtech/nice-recommends-hybrid-closed-loop-systems-type-1-diabetes-prompting-praise-medtronic XX     Commercial XX Kyle Banks was diagnosed with type 1 diabetes on November 1, 2015 while performing with the traveling production of Disney's The Lion King.  Performing nightly for sold out audiences across the country was a dream come true, but after experiencing symptoms of the onset of type 1 diabetes, the dream temporarily turned into a nightmare. The symptoms he experienced were  typical for the onset of this chronic illness. but with limited knowledge of type 1 diabetes, he had no idea what was occurring or the drastic life change that would soon follow.  In 2020, he founded Kyler Cares in partnership with Children's Hospital New Orleans and has since connected with families from across the country that are living with this disease.  Kyler Cares seeks to improve health outcomes for people of color living with diabetes and ensuring families can access the resources and technology available for better management is the route the organization is taking to achieve that goal. At Kyler Cares we're working to improve health outcomes for people of color living with diabetes by improving access to diabetes technology, creating connections to education and resources, and fostering community as an added system of support on our journeys. Kyler Bear & Friends' T1 Diaries is an eight-part animated series for kids, dedicated to storytelling about life with Type 1 Diabetes. Our series is more than just an educational tool; it's a reflection of real-life stories and an avenue to strengthen community ties. It's a vehicle for us to inspire young people to begin laying a foundation of knowledge and self-confidence with management of T1D that will resonate throughout their lives until a cure for the disease is discovered.   By supporting this series with a donation, you will be contributing to a project that not only educates and informs but also offers comfort and a sense of belonging to kids navigating life with T1D. ‘Kyler Bear's T1 Diaries' isn't just a series; it's a beacon of hope, a source of information, and a testament to the strength found in our amazing T1D community. Join us in bringing these stories to life XX Married At First Sight UK ends this week, but one bride says viewers haven't seen her whole story.   Fans will find out if Tasha Jay, 25, decides to stay with partner Paul Liba on the Channel 4 show.   But Tasha, who has type 1 diabetes, has spoken out about how footage about her condition didn't make the final cut.   While she's "really sad" that it was left out, Tasha's pleased that people are now realising why she behaved in a certain way on the show at times.     Married at First Sight - or MAFS - is a social experiment where experts match complete strangers who try to live as a couple.   Tasha says her wedding day with Paul on the show was a "really beautiful moment" that included her telling Paul about her diabetes and his reaction.   "I got filmed taking my insulin and checking my blood sugar," she tells BBC Newsbeat.. Tasha was diagnosed at aged two and half and says people have asked why that part of her was hidden in the show.   "And I'm like I didn't hide it," she says.   "For whatever reason they haven't shown it, which really upsets me because diabetes is a part of my story."   Tasha believes that, if people had known about her diabetes, it would have changed their perception of certain moments in the show. https://www.bbc.com/news/newsbeat-67368445

Tuesday, November 14, was World Diabetes Day. We spoke with general practitioner Dr. Ali Ziabari from Melbourne about the impact of diabetes in Australia. Dr Ziabari spoke about the types of diabetes, the treatments for it, the causes and symptoms of diabetes. According to the 2021 Census, more than 1 in 20 Australians have diabetes. The disease is particularly common among older Australians, affecting almost 1 in 5 people aged 80-84. - Roja Sêşemê 14î Mijdarê Roja Navnetewî ya Nixweşiya Şekirî bû. Em derbarê nixweşiya şêkir bi doktorê gîştî Dr Elî Zêbarî ji Melbourne diaxafin.Li seranserê cîhanê ji 10 mezinan 1 bi nixweşiya şêkir e. Zêdetirî ji sedî 90 cureya du hene. Nêzîkî nîv jî hîn nehatine tespît kirin. Di pir rewşan de, cure 2 ji nixweşiya şekirî tevliheviyên wê bi pejirandin û domandina adetên tendurist dikarin dereng yan pêşî li nixweşiyê werin girtin. Lê li Australya li gorî serjimêriya 2021 wate Census zêdetirî 1 ji 20 Australiyan nixweşiya şekirî hebûn. Ev nixweşî bi taybetî di nav Australiyên temen mezin de heye, hema hema 1 ji 5 kesên di temenê 80-84 salî de hene.

Hello lovelies! In honour of World Diabetes Day on 14th November, please enjoy this special solo episode where I talk through 14 lessons that have helped me to live better with type 1 diabetes.I've gone from 'surviving' (just) with type 1 diabetes to really living in vibrant, messy technicolour, and while I still have my frustrating diabetes days, I have come a very long way in terms of the tools, structures and understanding I have of my chronic condition.This episode is designed to be delivered as a big encouraging hug, because we're all doing enough if we're trying - you are enough and you are not alone. There is no actual medical advice in here, but I hope this episode finds the people who need it.I'll be back next week with another fabulous guest, but let me know on Instagram what you think of this one as it's very different from the usual. And Happy World Diabetes Day for everyone doing their best to gobble up everything that life has to offer despite this chronic chaos. I appreciate you being on this journey with me!FIND ME ON INSTAGRAM

Amanda kicks things off with health awareness on World Diabetes Day, reminding us to be mindful of what we consume, even for our furry friends. National Seat Belt Day urges us to buckle up for a fantastic show ahead. Blackurate News delves into Lloyd's of London's apology for its role in slavery, sparking a discussion on reparations. The Voting and Venting segment features listener calls on various voting-related topics. SAG-AFTRA's resolution with Hollywood studios after a 100-day strike is explored, with Amanda weighing in on key aspects. A Color Purple quiz for team members adds a fun twist, followed by a thought-provoking segment on Whoopi Goldberg's views on millennials and Gen Z-ers' work ethic. The episode wraps with insights on recent headlines, a Color Purple quiz, and Amanda's witty take on politicians.   Listen, Laugh, and Learn with The Amanda Seales Show   FOLLOW ALONG AS WE COVER:   (4:58) - Whoopi Goldberg is receiving backlash after suggesting millennials and Gen Z-ers have poor work ethic. A recent episode on “The View” featured the hosts discussing the current economic climate, including housing, finances, and being parents. Let's hear Whoopi's comments.   (9:50) - It's time for our new segment– Voting and Venting! This is your opportunity (and mine) to vent about anything related to voting– contemplating who should get your vote? Vexed about certain laws being voted on in your city? We wanna hear about it! It's time to vent. Let's go to the phone lines.   (14:17) - 60 Second Headlines   Beyoncé dropped a brand new trailer for her upcoming tour film. The movie takes us behind the scenes of her Renaissance world tour. NY Attorney General Letitia James has announced that Uber and Lyft will start laying plans to implement a minimum wage and paid sick leave for drivers in the New York area. Dr. Jill Stein has announced a surprise presidential bid, seeking the Green Party's 2024 nomination! Atlanta's nightlife may get a boost as the city proposes to extend “last call” from 2:30 am until 4 am under the Atlanta Hospitality Act. A Judge has granted prosecutors the right to present a collective of Young Thug's rap lyrics in the trial against him and his YSL associates amid their controversial RICO case.   (17:06) – We'll go to the phone lines.   (21:29) - Coming up this hour in Blackurate News:   The UK insurance market, Lloyd's of London, says they are deeply sorry for their role in the slave trade. That's it? Sorry?! Also, after over 100 days, the actors' strike is over. We'll highlight some of the terms of the deal. Plus, the Big Up/Let Down… The Big Up goes to a flight attendant, and the Let Down goes to some teeth… I'll explain in a minute!   (26:00) - Lloyd's of London, the giant U.K. insurance and reinsurance market founded in 1688, has apologized for its historic link to slavery. “We are deeply sorry for the Lloyd's market's participation in the transatlantic slave trade. It is part of our shared history that caused enormous suffering and continues to have a negative impact on Black and ethnically diverse communities today.” Lloyd's announced steps to make amends, including investing the equivalent of $48.8 million and introducing comprehensive initiatives to tackle inequality toward Black and ethnically diverse individuals.   (30:08) - After over 100 days of picketing, SAG-AFTRA struck a new tentative deal with Hollywood's major studios -- effectively ending the actors' strike. The 118-day strike was one of the longest labor outages in Hollywood history. Among the studio heads who came to the negotiating table during the SAG strike were Bob Iger of Disney, Donna Langley of NBCUniversal Studio Group, Ted Sarandos of Netflix, and David Zaslav of Warner Bros. Discovery.   (35:47) – The Big Up/Let Down:   Big Up - In a viral post, a Grammy-nominated gospel singer named Bobbi Storm went head-to-head with a flight attendant after she wanted to serenade the whole flight with a song, and he shut her all the way down!!!! Big Up - To this flight attendant for not taking her to Jesus for all this racket. This was completely out of order! People are trying to sleep! What if you woke somebody's baby up?! You can't just hijack the plane with your voice. Even if it is pretty. She was trying to give herself the glory, not Jesus! Also, big up to the folks with noise-canceling headphones who heard none of this! Let Down: Rapper and toxic partner in crime to Blueface, Chrisean Rock, joined Tamar Braxton onstage at a concert this past weekend but she didn't leave before allegedly assaulting, James Wright, Tamar's stage hand (famous for his Patti Pies review). She supposedly caused a severe nosebleed and chipped his tooth. The letdown goes to…. these weak ass 2023 teeth!   (41:09) – We'll go to the phone lines. 1-855-262-6328.   (43:20) - Coming up: We're gonna give Rita and TJ, who have never seen the original Color Purple movie, a Color Purple Quiz!   (46:15) – We'll play the Color Purple Quiz.   (52:44) – The actors' strike is over! Amanda gives more insight.   (57:25) – We'll go back to the phone lines.   (1:00:46) - It's time to listen, laugh, and learn… with the Word of the Day. The Word of the Day is: Bugbear - Noun A source of dread or irritation; something that causes problems or annoys people.   (1:04:08) – Politicians say the smartest things.   (1:08:54) – Thanks for listening to The Amanda Seales Show.   FOLLOW THE SHOW ON ALL SOCIALS: @Sealessaidit @Amandaseales @Jeremiahlikethebible If You Have A Comment Leave Amanda A Message At 1 855-Amanda-8 That's 1-855-262-6328  See omnystudio.com/listener for privacy information.

November 14th is World Diabetes Day. My daughter lives with Type 1 Diabetes and this day is very near and dear to my heart. In honor of Dr. Banting, who discovered insulin in 1921, we are talking about sharing your gifts with the world. It's time to stop sitting around feeling scared to try. You never know how you could change someone else's life! Get the show notesGo behind the scenes with me on IG @IrresistibleIcingHead over to the free Irresistible You Podcast Discussion Group to continue the conversation about this episode and more!Support the podcast by leaving a free rating & review on Apple Podcasts or buy me a coffee.Support the show

As we observe World Diabetes Day, we delve into the complex landscape of diabetes in China and beyond. From skyrocketing cases to the influence of lifestyle, we dissect the sweet dilemma that millions face daily. Join us as we examine the multifaceted factors that contribute to the rise of diabetes, question how the world can collectively combat the silent epidemic of diabetes. On the show: Niu Honglin, Xingyu & Brandon Yates

Yesterday was World diabetes day, a day to raise awareness about diabetes and battle some of the stigma around the disease.  This morning Rawan spoke with Dr Anna Serlachius, senior lecturer of Psychological Medicine at the University of Auckland, about a new research project looking at stigma and discrimination amongst those with diabetes. Rawan asked her about the importance of world diabetes day, what her research found about diabetes stigma and what we and the health system can do to make it easier for those with diabetes.

14 November 2023. We find out where the UAE is listed in the latest diabetes report. November is a month to check on our men, so Helen chats to Essa and Carlos who are encouraging men to open up more. Dr Yasir is giving us the latest stats when it comes to men's mental health. Why are some people addicted to shopping, we ask Dr Thoraiya. Youth Talks and Madhumita Adhya are both tapping in to the brains and the concerns of young people.See omnystudio.com/listener for privacy information.

National statistics prove we are way too reliant on our phones. Data shows: Americans check their phones 144 times per day -- 89% of Americans say they check their phones within the first 10 minutes of waking up -- 75% of Americans feel uneasy leaving their phone at home…you get the point! Counselor, Julius Dudics, talks about phone addiction and how to create boundaries for kids AND adults. (0:00) Ahead of the cold months and gift giving season, we focused on animal cruelty. Do people know how to handle pets in the cold? And do you know how to detect puppy mill purchases? Virginia Maxwell from UNH shares her professional insight on this. (14:20) It is World Diabetes Day and we wanted to focus especially on detecting pre-diabetes. More than 1 in 3 people are pre-diabetic, but most have no idea. We spoke with Dr. Christopher Holliday from the CDC about testing for pre-diabetes and how to reverse the problem. (29:45) AAA projects 55.4 million travelers will journey 50 miles or more from home over the Thanksgiving holiday, defined as Wednesday November 22 to Sunday the 26th. The travel volume this year reflects an increase of 2.3% over last year and marks the third-highest Thanksgiving travel since AAA began tracking in 2000. We spoke with Alec Slatky of AAA about the findings and what people should know ahead of next week. (38:30). Image Credit: Getty Images

In support of World Diabetes Day on November 14th, I explore how a Keto Detox Cleanse may help with diabetes prevention. Discover how dietary and lifestyle changes in combination with the right supplements and detox program can help correct bloody sugar levels and prevent the onset of diabetes.SARA BANTA HEALTH TALKS is broadcast live Mondays at 5PM ET.SARA BANTA HEALTH TALKS is viewed on Talk 4 TV (www.talk4tv.com).SARA BANTA HEALTH TALKS is broadcast on W4CY Radio (www.w4cy.com) part of Talk 4 Radio (www.talk4radio.com) on the Talk 4 Media Network (www.talk4media.com). SARA BANTA HEALTH TALKS is also available on Talk 4 Podcasting (www.talk4podcasting.com), iHeartRadio, Amazon Music, Pandora, Spotify, Audible, and over 100 other podcast outlets.

This podcast episode is all about your wins as listeners for WORLD DIABETES DAY and, of course, a whole lot of waffle, chicken, and Kit Kats with Mike and Jack!  Wins and Struggles still get an appearance though as you stay up to date with Mike and Jack. After six long months of battling himself, Jack has officially done it!  Who knew beating a gaming console could be this intense? Congrats, Jack - battles with technology got real with his struggle though!  Mike is taking 'carb-loading' to a whole new level and weighing his food like a pro! But his daily battle with hypoglycemia makes him fashionably late for work. Who needs an alarm when you've got a Libre 2 sensor? Follow The Podcast https://www.instagram.com/wearet1d Follow Mike https://www.instagram.com/t1d_mike Follow Jack https://www.instagram.com/t1d_jack Get your wins on the podcast at https://wearet1d.com New episodes - Every Sunday! Follow & Share

Today is a special World Diabetes Day feature, and in a very fitting manner, Eoin goes low while recording.Eoin and Graham cover a massive amount throughout this episode:Eoin going low while recording.Joining Eoin's email list (link below).Bursting through trampolines.How to thank your Diabetes.Identifying what serves you, and what doesn't.Flipping perspective to benefit you.And much, MUCH more!As always, be sure to rate, comment, subscribe and share. Your interaction and feedback really helps the podcast. The more Diabetics that we reach, the bigger impact we can make!Questions & Stories for the Podcast?:theinsuleoinpodcast@gmail.comConnect, Learn & Work with Eoin:https://linktr.ee/insuleoin Hosted on Acast. See acast.com/privacy for more information.